Uncoupling Protein 2 Knockout Mice Have Enhanced Insulin Secretory Capacity After a High-Fat Diet
- Jamie W. Joseph1,
- Vasilij Koshkin1,
- Chen-Yu Zhang2,
- Jing Wang1,
- Bradford B. Lowell2,
- Catherine B. Chan3 and
- Michael B. Wheeler1
- 1Departments of Medicine and Physiology, University of Toronto, Ontario, Canada
- 2Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
- 3Department of Anatomy and Physiology, Atlantic Veterinary College, University of Prince Edward Island, Prince Edward Island, Canada
Abstract
Uncoupling protein 2 (UCP2) may act as an important regulator of insulin secretion. In this study, β-cell function in UCP2-deficient mice was examined after a 45% high-fat diet (HFD) to assess its role during the development of diet-induced type 2 diabetes. HFD-fed UCP2 (−/−) mice have lower fasting blood glucose and elevated insulin levels when compared with wild-type (WT) mice. UCP2 (−/−) mice also have enhanced β-cell glucose sensitivity compared with WT mice after HFD, a result that is due in part to the deterioration of glucose responsiveness in WT mice. HFD-fed UCP2 (−/−) mice have increased insulin secretory capacity as a result of increased pancreatic β-cell mass and insulin content per islet. Islets from WT mice exposed to 0.5 mmol/l palmitate for 48 h have significantly reduced mitochondrial membrane potential, ATP concentrations, and glucose responsiveness compared with UCP2 (−/−) islets, suggesting that elevated UCP2 in WT mice increases proton leak and decreases mitochondrial ATP production. Highly increased carnitine palmitoyl transferase-1 gene expression in UCP2 (−/−) mice is suggestive of enhanced fatty acid oxidizing capacity, particularly after HFD stress. These results further establish UCP2 as a component in glucose sensing and suggest a possible new aspect of UCP2 function during the progression of type 2 diabetes.
Footnotes
-
Address correspondence and reprint requests to Michael B. Wheeler, Department of Physiology, University of Toronto, 1 King’s College Circle, Room 3352, Toronto, ON, M5S 1A8, Canada. E-mail: michael.wheeler{at}utoronto.ca.
Received for publication 15 November 2001 and accepted in revised form 4 July 2002.
AUC, area under the curve; BrdU, 5-bromo-2′deoxyuridine; CPT-1, carnitine palmitoyltransferase 1; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSIS, glucose-stimulated insulin secretion; HFD, high-fat diet; IPGTT, intraperitoneal glucose tolerance test; ITT, insulin tolerance test; ROS, reactive oxygen species; UCP, uncoupling protein.
- DIABETES














